← Back to Venmax Drugs & Pharmaceuticals Inc Overview

📊Financials 📈PE Ratio 🥧Shareholding 💰Dividend 📋Quarterly ⚖️Balance Sheet 💹P&L 🌊Cash Flow

VENMAXPharmaceuticals

Venmax Drugs & Pharmaceuticals Inc — Financial Ratios & Key Metrics

₹25.77

-2.15%

P/E Ratio45.94xIndustry: 31.77x

ROE6.38%Return on equity

ROCE5.29%Return on capital

Debt/Equity0.36Low debt

💎

Valuation & Profitability

P/E Ratio

45.94x

Industry Average P/E

31.77x

Dividend Yield

0.00%

Market Cap

₹15.62 (Cr)

Sales Growth 5Y

11.50%

Profit Growth 5Y

19.57%

EPS Growth 5Y

19.57%

OPM 5Y Avg

N/A

📉

Price Returns

1 Month

+6.43%

3 Months

+3.51%

6 Months

+23.24%

1 Year

+N/A

52W Low

₹19

Current

₹26

52W High

₹37

38% of 52-week range — Near lows

🔬

Technical Indicators

Neutral

Momentum is balanced — neither overbought nor oversold.

SMA 50

₹26

▲ Price above SMA 50 — Bullish

SMA 200

₹26

▼ Long-term downtrend

Volume Signal

22% of avg

Below average volume — low conviction

Technical indicators are for educational purposes only. Not investment advice.

More on Venmax Drugs & Pharmaceuticals Inc

Overview Financials PE History Shareholding Quarterly Balance Sheet P&L Cash Flow Pharmaceuticals Stocks Screener

Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.